Sunday, January 25, 2015

Hot Long Term Stocks To Watch For 2014

The recent Air & Space Conference near Washington, D.C., was an incredible display of some of the finest defense technologies in the world. Lockheed Martin (NYSE: LMT  ) showed off several products, including a giant three-dimensional long-range radar system, which will be used by the Air Force for mobile, long-range surveillance and ballistic missile defense.

The Motley Fool's roving reporter Rex Moore was at the conference, and talked with Lockheed's director of ground-based surveillance radar, Mark Mekker. In this first of four installments, Mekker explains exactly what this 3-D system is capable of.

Dividend Stocks Can Make You Rich�
It's as simple as that. While they don't garner the notoriety of high-flying growth stocks, they're also less likely to crash and burn. And over the long term, the compounding effect of the quarterly payouts, as well as their growth, adds up faster than most investors imagine. With this in mind, our analysts sat down to identify the absolute best of the best when it comes to rock-solid dividend stocks, drawing up a list in this free report of nine that fit the bill. To discover the identities of these companies before the rest of the market catches on, you can download this valuable free report by simply clicking here now.

5 Best Chemical Stocks To Own Right Now: Ocean Power Technologies Inc.(OPTT)

Ocean Power Technologies, Inc. engages in the development and commercialization of proprietary systems that generate electricity by harnessing the renewable energy of ocean waves primarily in North America, Europe, Asia, and Australia. The company offers utility PowerBuoy system to supply electricity to a local or regional electric power grid; and autonomous PowerBuoy system that is designed to generate power for use independent of the power grid in remote locations. Its autonomous PowerBuoy system is also used in various applications, including homeland security, off-shore oil and gas platforms, aquaculture, and ocean-based communication and data gathering, such as tsunami warnings. The company sells its products to public utilities, independent power producers, and other governmental entities and agencies, as well as public and private entities that use electricity in and near the ocean. Ocean Power Technologies, Inc. was incorporated in 1984 and is headquartered in Penn ington, New Jersey.

Advisors' Opinion:
  • [By Konrad Kuhn]

    Ocean Power Technologies (OPTT) is a pioneer in wave energy technology that harnesses ocean wave resources, to generate clean and environmentally-beneficial electricity.

Hot Long Term Stocks To Watch For 2014: Realty Income Corporation(O)

Realty Income Corporation engages in the acquisition and ownership of commercial retail real estate properties in the United States. The company leases its retail properties primarily to regional and national retail chain store operators. As of December 31, 2006, it owned 1,955 retail properties located in 48 states, covering approximately 16.7 million square feet of leasable space. The company also held a portfolio of 60 properties through its wholly owned subsidiary, Crest Net Lease, Inc. (Crest), as of the above date. Realty Income Corporation has elected to be treated as a real estate investment trust (REIT) under the Internal Revenue Code. As a REIT, it would not be subject to federal income taxes provided it distributes at least 90% of its taxable income to its shareholders. The company was founded in 1969 and is based in Escondido, California.

Advisors' Opinion:
  • [By Brad Thomas]

    Other REITs mentioned: (O), (NNN), (STAG), (DCT), (EGP), (PDM), (DRE), (LRY)

    Source: Chambers Street: More Liquidity Magic On The Way In REIT-Dom

    Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. (More...)

  • [By Russ Krull]

    Realty Income (NYSE: O  ) leased $750 million for 10 years. The money will be used repay the company's acquisition credit facility. Realty Income is a Real Estate Investment Trust that pays monthly dividends.

  • [By Jonas Elmerraji]

    They call Realty Income (O) the "monthly dividend company." The $10 billion retail REIT has been paying out a monthly dividend for the last 44 years, making it an especially attractive name for investors who need faster-paced income streams. It's a hefty payout too: Those monthly dividend checks add up to a 4.5% yield at current price levels.

    Realty Income has interests in more than 3,600 properties, the vast majority of which are freestanding single-tenant retail units. Like HCP, Realty Income signs long-term triple-net leases with its tenants, a necessary component of being able to pay out consistent income each month. The long-term nature of Realty Income's tenants is another key to its financial health – on average less than 3% of tenants are up for renewal each year, which means that occupancy rates have a pretty strong floor built-in.

    Financially, Realty Income is in excellent shape – just don't compare the firm's balance sheet outside of the sector. Obviously, the REIT business is capital intense, and since REITs have to pay out the vast majority of income to investors, it's very difficult to build up a war chest. That said, Realty Income sports relatively low leverage and plenty of untapped credit. This trust is a good go-to for any income investor's portfolio right now.

Hot Long Term Stocks To Watch For 2014: CEL-SCI Corp (CVM)

CEL-SCI Corporation (CEL-SCI), incorporated on March 22, 1983, is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology, with two products, hemagglutinin type 1 and neuraminidase type 1 (H1N1) swine flu treatment for H1N1 hospitalized patients and CEL-2000, a rheumatoid arthritis treatment vaccine.

Multikine

CEL-SCI's Multikine, is being developed for the treatment of cancer. It is a cancer immunotherapy drugs called Combination Immunotherapy because it combines active and passive immunity in one product. It is the only cancer immunotherapy that both kills cancer cells and activates the general immune system to destroy the cancer. Multikine target the tumor micro-metastases for treatment failure. Multikine is also applicable in many other solid tumors.

New Manufacturing Facility

CEL-SCI's facility manufactures Multikine for CEL-SCI's Phase III clinical trial. CEL-SCI offers the use of the facility as a service to pharmaceutical companies and others, particularly those that need to fill and finish their drugs in a cold environment. Fill and finish is the process of filling injectable drugs in a sterile manner.

LEAPS

CEL-SCI's patented T-cell Modulation Process uses heteroconjugates to direct the body to choose a specific immune response. The heteroconjugate technology, referred to as LEAPS, is intended to stimulate the human immune system to fight bacterial, viral and parasitic infections, as well as autoimmune, allergies, transplantation rejection and cancer. Administered like vaccines, LEAPS combines T-cell binding ligands with small, disease associated and peptide antigens.

Using the LEAPS technology, CEL-SCI has created a peptide treatment for H1N1 (swine flu) hospitalized patients. This LEAPS flu treatment is designed to focus on the conserved, non-changing epitopes of the di! fferent strains of Type A Influenza viruses, including swine, avian or bird, and Spanish Influenza. CEL-SCI's LEAPS flu treatment contains epitopes.

Advisors' Opinion:
  • [By Bryan Murphy]

    It may not have blazed a trail into the young, immunology segment of the biotech industry the way Dendreon Corporation (NASDAQ:DNDN) did back in 2010 with the debut of Provenge. It may not have the same immunology pipeline (and company size) that ImmunoGen, Inc. (NASDAQ:IMGN) boasts. One thing is pretty certain about cancer-immunotherapy developer CEL-SCI Corporation (NYSEMKT:CVM) right now, however - its stock may be poised to dole out a much bigger foreseeable-future reward than DNDN or IMGN are.

  • [By Bryan Murphy]

    To say that 2014 has been a good year so far for CEL-SCI Corporation (NYSEMKT:CVM) would be an understatement. It's been a great year for the company, and more specifically, its shareholders. CVM is up 96% year-to-date, cutting into a big chunk of the loss that was suffered in 2013. And, though a near-doubling in less than a month would normally be an invitation to a painful wave of profit-taking, in the case of CEL-SCI, the situation says this is one of those rallies that could get hotter the hotter it gets.

  • [By Bryan Murphy]

    Look out AbbVie Inc. (NYSE:ABBV), and Gilead Sciences, Inc. (NASDAQ:GILD), you may want to look over your shoulder as well. There's a new immunology player coming to town, and its name is CEL-SCI Corporation (NYSEMKT:CVM). Yes, AbbVie may be the name behind blockbuster drug Humira - with nearly $10 billion in sales in 2012 - while Gilead Sciences is saving HIV patients' lives with immunological therapies Stribild and Complera. But, small cap company CEL-SCI may be closer to launching its own immunology drug sooner than most investors realize.

Hot Long Term Stocks To Watch For 2014: Cabot Corp (CBT)

Cabot Corporation (Cabot), incorporated in 1960, is a global specialty chemicals and performance materials company. The Company�� principal products are rubber and specialty grade carbon blacks, fumed metal oxides, inkjet colorants, aerogels and cesium formate drilling fluids. Cabot and its affiliates have manufacturing facilities and operations in the United States and approximately 20 other countries. The Company operates in four business segments: the Core Segment, the Performance Segment, the New Business Segment and the Specialty Fluids Segment. It is organized into three geographic regions: The Americas; Europe, Middle East and Africa, and Asia Pacific. On January 23, 2012, the Company sold its Supermetals Business to Global Advanced Metals Pty Ltd. On August 1, 2012, it acquired Norit.

Core Segment

Carbon black is a form of elemental carbon that is manufactured in a highly controlled process to produce particles and aggregates of varied structure and surface chemistry, resulting in many different performance characteristics for a variety of applications. Its rubber blacks products are used in tires and industrial products. The Company owns, or has a controlling interest in, and operates plants that produce rubber blacks in Argentina, Brazil, Canada, China, Colombia, the Czech Republic, France, Indonesia, Italy, Japan, Malaysia, The Netherlands and the United States.

Performance Segment

The Performance Segment consists of two product lines: specialty grades of carbon black and thermoplastic concentrates; and fumed silica, fumed alumina and dispersions thereof. In each product line, it designs, manufactures and sells materials that deliver performance in a range of customer applications across the automotive, construction and infrastructure, and electronics and consumer products sectors. In addition, Cabot manufactures and sources thermoplastic concentrates and compounds that are marketed to the plastics industry. The Company owns, or has a ! controlling interest in, and operates plants that produce specialty grades of carbon black in China, The Netherlands and the United States. Its products are produced in facilities that it owns, or has a controlling interest in, located in Belgium, China and the United Arab Emirates. The Company also owns, or has a controlling interest in, manufacturing plants that produce fumed metal oxides in the United States, China, the United Kingdom and Germany. During the fiscal year ended September 30, 2011 (fiscal 2011), it closed its masterbatch manufacturing facility in Grigno, Italy.

New Business Segment

The Company�� New Business Segment consists of the Inkjet Colorants, Aerogel, Cabot Superior MicroPowders and Cabot Elastomer Composites Businesses. During fiscal 2011, its Cabot Elastomer Composites Business became part of its New Business Segment. The Company produces and sells aqueous inkjet colorants primarily to the inkjet printing market. Its inkjet colorants are produced for various inkjet printing applications, including small office and home office, corporate office, and commercial and industrial printing, as well as for other applications. Its inkjet colorants are manufactured at its facility in Haverhill, Massachusetts.

Cabot�� aerogel is a hydrophobic, silica-based particle with a high surface area that is used in a variety of thermal insulation and specialty chemical applications. In the construction industry, the product is used in insulative composite building products and translucent skylight, window, wall and roof systems for insulating eco-daylighting applications. In the oil and gas industry, aerogel is used to insulate subsea pipelines. In the specialty chemicals industry, the product is used to provide matte finishing, insulating and thickening properties for use in a variety of applications. It manufactures its aerogel products at its facility in Frankfurt, Germany.

The Company manufactures its aerogel products at its facility in F! rankfurt,! Germany. Finished products for use in the oil and gas industry are fabricated at a facility in Billerica, Massachusetts. The principal area of commercial focus for Cabot Superior MicroPowders Business (CSMP) is in developing covert taggants for a range of anti-counterfeiting security applications. Development and manufacturing activities are conducted primarily at its facilities in Albuquerque, New Mexico and Mountain View, California. In addition to the carbon black the Company makes using conventional carbon black manufacturing methods, it has developed elastomer composite products that are compounds of natural latex rubber and carbon black made by a liquid phase process. Its Cabot Elastomer Composites Business (CEC) products are targeted for tire, defense, mining, automotive and aerospace applications. It manufactures CEC products at its facility in Port Dickson, Malaysia.

Specialty Fluids Segment

The Company�� Specialty Fluids Segment produces and markets cesium formate as a drilling and completion fluid for use primarily in high pressure and high temperature oil and gas well construction. It has a mine and a cesium formate manufacturing facility in Manitoba, Canada, as well as fluid blending and reclamation facilities in Aberdeen, Scotland and in Bergen and Kristiansund, Norway.

The Company competes with Aspen Aerogel, Inc.

Advisors' Opinion:
  • [By Eric Volkman]

    Cabot (NYSE: CBT  ) has elected not to shift its dividend policy for the time being. The company declared its latest common stock distribution, which is to be $0.20 per share paid on September 13 to shareholders of record as of August 30.�That amount matches each of the firm's previous five distributions, the most recent of which was handed out in the middle of last month. Prior to that, Cabot paid $0.18 per share.

  • [By Victor Selva]

    The company has a current ratio of 17.8% which is higher than the industry mean of 6.55%. Also, it's higher than the one registered by Akzo Nobel NV (AKZOY), Cabot Corporation (CBT) and Olin Corporation (OLN). For investors looking for a higher ROE, PPG Industries Inc. (PPG) could be the option.

Hot Long Term Stocks To Watch For 2014: Grupo Financiero Galicia S.A. (GGAL)

Grupo Financiero Galicia S.A. operates as a financial services holding company in Argentina. The company offers financial products and services, including collection and payment services, commercial credit cards, direct payroll deposits, capital market alternatives, foreign trade solutions, and corporate e-banking solutions; corporate debt transactions and securitization transactions; and e-collection and payment solutions to various agencies, municipalities, and universities. It also provides a range of financial products and services, such as transactions, loans, and investments; and checking and savings accounts, credit and debit cards, payroll direct deposits, insurance, and retirement and pension payments. In addition, the company offers mutual funds and in brokerage services; manages positions in foreign currency and government securities; acts as an intermediary and distributes financial instruments for institutional investors, corporate customers, and individuals; and enables customers to buy and sell securities on the Buenos Aires Stock Exchange. Further, it provides life insurance products, including employee benefit plans and credit related insurance; and property and casualty insurance products, such as home and ATM theft insurance. As of December 31, 2012, the company operated 257 full service banking branches and 1,676 ATMs and self-service terminals. Grupo Financiero Galicia S.A. was founded in 1905 and is based in Buenos Aires, Argentina.

Advisors' Opinion:
  • [By Federico Zaldua]

    Grupo Financiero Galicia (GGAL), which was once owned by Rob Citrone's hedge fund Discovery Capital Management, owns one of Argentina's biggest private banks by deposits and the fastest growing within the banks that count with national presence. As a matter of fact, according to management, "the bank's estimated market share of loans to private sector was 9.10% growing 56 basis points from a year before and the market share of deposits from the private sector was 8.98% growing 28 basis points in the year."

Hot Long Term Stocks To Watch For 2014: Parametric Technology Corporation(PMTC)

Parametric Technology Corporation develops, markets, and supports product lifecycle management (PLM) software solutions and services that help companies design products, manage product information, and enhance product development processes worldwide. Its PLM solutions comprise Windchill, an Internet-based content and process management solution for managing data and relationships, processes, and publications; Arbortext, an enterprise solution to manage complex information assets that enhance their customer support and service center information delivery processes; Creo View, which enables enterprise-wide visualization, verification, annotation, and automated comparison of various product development data formats; and Integrity that coordinates and manages various activities and artifacts associated with developing software-intensive products. The company?s desktop solutions include Creo Parametric, a family of three-dimensional product design solutions based on a parametr ic, feature-based solid modeler that enables changes made during the design process to be associatively updated throughout the design; Creo Elements/Direct, a family of computer aided design and collaboration software used for customers to meet short design cycles and to create product designs; Mathcad, an engineering calculation software solution, which combines a computational engine, accessed through conventional math notation, and with a full-featured word processor and graphing tools; and Arbortext to help customers improve documentation accuracy, speed time to market, reduce translation requirements, and lower publishing costs. In addition, it provides consulting, implementation, training, maintenance, and computer-based training products. Parametric Technology sells its products and services through direct sales force and third-party resellers and other strategic partners. The company was founded in 1985 and is headquartered in Needham, Massachusetts.

Advisors' Opinion:
  • [By Northrop Puckett]

    The company is facing headwinds in the broader economy. This can be seen in declining sales in many areas of their business. Regionally, the U.S was flat; Northern Europe was up; Southern Europe was down; and emerging markets were down. Autodesk also lowered quarterly and yearly revenue expectations. This lowering of guidance by Autodesk also matches the same guidance changes made by competitors Parametric Technology (PMTC) and ANSYS (ANSS), so it is not necessarily losing out to its rivals in this case.

  • [By Eric Volkman]

    PTC (NASDAQ: PMTC  ) results for the company's Q2 have been released. For the quarter, non-GAAP revenue was just under $315 million, which bettered the $302 million the company posted in the same period the previous year. Net profit also saw an increase, advancing to $49.6 million ($0.41 per diluted share) from Q2 2012's $35.9 million ($0.30).

  • [By Markus Aarnio]

    Autodesk's competitors include Adobe Systems (ADBE), Dassault Systemes SA (DASTY.PK), and Parametric Technology Corporation (PMTC). Here is a table comparing these companies.

Hot Long Term Stocks To Watch For 2014: IMS Health Holdings Inc (IMS)

IMS Health Holdings, Inc., incorporated on October 23, 2009, is a global information and technology services company providing clients in the healthcare industry with comprehensive solutions to measure and improve their performance. It has collections of healthcare information in the world, spanning sales, prescription and promotional data, medical claims, electronic medical records and social media. Its scaled and data set, containing over 10 petabytes of data, includes over 85% of the world�� prescriptions by sales revenue and approximately 400 million comprehensive, longitudinal, anonymous patient records. It serves healthcare organizations and decision makers around the world, spanning the breadth of life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community.

The Company uses healthcare-specific global information technology (IT) infrastructure to process data from over 45 billion healthcare transactions annually and to collect data from over 780,000 fragmented feeds globally, which it organize in a structured fashion using methodologies. Its intelligent cloud, IMS One opens its global IT infrastructure to its clients and provides the ability to perform business analytics in the cloud with large amounts of complex data. Its principal offerings include National information offerings; Sub-national information offerings; Commercial services; Real-World Evidence (RWE) solutions; Commercial technology solutions, and Clinical solutions.

The Company�� national offerings includes services in more than 70 countries that provide consistent country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment and promotional activity across multiple channels including retail, hospital and mail order. Its sub-national offerings includes services in more than 50 ! countries that provide a consistent measurement of sales or prescribing activity at the regional, zip code and individual prescriber level. The Company provides a set of strategic, analytic and support services to help the commercial operations of life sciences companies transform their commercial models. It integrate information from medical claims, prescriptions, electronic medical records, biomarkers and government statistics into anonymous, longitudinal patient journeys that provide detailed views of treatment patterns, disease progression, therapeutic switching and concomitant diseases and treatments.

The Company provides a range of hosted and cloud-based applications and associated implementation services. The applications, hosted on IMS One, support a range of commercial processes including multi-channel marketing, customer relationship management (CRM), performance management, incentive compensation, territory alignment, roster management and call planning. It helps life sciences companies design and execute clinical trials, and for payers and providers, it enables risk-sharing, pay-for-performance and population health management.

Advisors' Opinion:
  • [By Jayson Derrick]

    After pricing its IPO at $20, shares of IMS Health (NYSE: IMS) began trading for the first time at $22.18, traded as high as $23.69 before closing the day at $23.00, up 15.00 percent.

No comments:

Post a Comment